Laboratory Of America Holdings PE Ratio 2006-2018 | LH

Current and historical p/e ratio for Laboratory Of America Holdings (LH) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Laboratory Of America Holdings PE ratio as of November 16, 2018 is 15.01.
Laboratory Of America Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-11-16 164.30 11.86
2018-09-30 173.68 $13.85 12.54
2018-06-30 179.53 $12.49 14.37
2018-03-31 161.75 $12.04 13.43
2017-12-31 159.51 $12.21 13.06
2017-09-30 150.97 $7.15 21.11
2017-06-30 154.14 $7.12 21.65
2017-03-31 143.47 $7.21 19.90
2016-12-31 128.38 $6.92 18.55
2016-09-30 137.48 $6.28 21.89
2016-06-30 130.27 $6.06 21.50
2016-03-31 117.13 $5.79 20.23
2015-12-31 123.64 $4.25 29.09
2015-09-30 108.47 $4.53 23.94
2015-06-30 121.22 $4.63 26.18
2015-03-31 126.09 $4.63 27.23
2014-12-31 107.90 $5.93 18.20
2014-09-30 101.75 $5.97 17.04
2014-06-30 102.40 $6.01 17.04
2014-03-31 98.21 $5.99 16.40
2013-12-31 91.37 $6.24 14.64
2013-09-30 99.14 $6.07 16.33
2013-06-30 100.10 $5.97 16.77
2013-03-31 90.20 $5.91 15.26
2012-12-31 86.62 $5.98 14.48
2012-09-30 92.47 $6.06 15.26
2012-06-30 92.61 $5.84 15.86
2012-03-31 91.54 $5.48 16.70
2011-12-31 85.97 $5.08 16.92
2011-09-30 79.05 $5.00 15.81
2011-06-30 96.79 $5.03 19.24
2011-03-31 92.13 $5.29 17.42
2010-12-31 87.92 $5.31 16.56
2010-09-30 78.43 $5.38 14.58
2010-06-30 75.35 $5.25 14.35
2010-03-31 75.71 $5.03 15.05
2009-12-31 74.84 $5.00 14.97
2009-09-30 65.70 $4.75 13.83
2009-06-30 67.79 $4.54 14.93
2009-03-31 58.49 $4.22 13.86
2008-12-31 64.41 $4.14 15.56
2008-09-30 69.50 $4.04 17.20
2008-06-30 69.63 $3.96 17.58
2008-03-31 73.68 $4.09 18.01
2007-12-31 75.53 $3.93 19.22
2007-09-30 78.23 $3.75 20.86
2007-06-30 78.26 $3.64 21.50
2007-03-31 72.63 $3.46 20.99
2006-12-31 73.47 $3.24 22.68
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.578B $10.441B
Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.839B 22.43
McKesson (MCK) United States $24.205B 9.25
AmerisourceBergen (ABC) United States $19.202B 13.70
Align Technology (ALGN) United States $18.029B 46.00
Cardinal Health (CAH) United States $16.524B 11.09
Henry Schein (HSIC) United States $13.120B 21.57
Cooper (COO) United States $13.023B 23.45
DENTSPLY SIRONA (XRAY) United States $8.279B 16.53
West Pharmaceutical Services (WST) United States $8.159B 40.49
Merit Medical Systems (MMSI) United States $3.360B 39.79
Patterson (PDCO) United States $2.427B 17.06
CONMED (CNMD) United States $1.929B 32.05
STAAR Surgical (STAA) United States $1.784B 183.77
Atrion (ATRI) United States $1.343B 38.40
Antares Pharma (ATRS) United States $0.532B 0.00
Invacare (IVC) United States $0.189B 0.00
Lifevantage (LFVN) United States $0.161B 22.84
Endologix (ELGX) United States $0.106B 0.00
Pro-Dex (PDEX) United States $0.061B 27.17
Aceto (ACET) United States $0.055B 0.00
Biolase (BIOL) United States $0.027B 0.00